Renejix CDMO Partner for Small Molecule Oral Dosage Forms Renejix CDMO Partner for Small Molecule Oral Dosage Forms

X

Digital content for AlzeCure Pharma AB

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
AlzeCure Pharma AB
Sweden Flag
Country
Country
Sweden
Address
Address
Hälsovägen 7, SE-141 57 Huddinge
Telephone
Telephone
559094-8302.
Linkedin
Linkedin
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

https://www.accesswire.com/907466/alzecure-publishes-its-interim-report-for-january-june-2024

ACCESSWIRE
26 Aug 2024

https://www.accesswire.com/viewarticle.aspx?id=900091&lang=en

ACCESSWIRE
12 Aug 2024

https://www.accesswire.com/viewarticle.aspx?id=897328&lang=en

ACCESSWIRE
07 Aug 2024

https://www.accesswire.com/viewarticle.aspx?id=876905&lang=en

ACCESSWIRE
13 Jun 2024

https://www.accesswire.com/863497/eli-lillys-and-astrazenecas-former-head-of-research-dr-jan-lundberg-elected-as-a-new-board-member

ACCESSWIRE
15 May 2024

https://www.accesswire.com/862385/alzecure-reports-anti-inflammatory-effects-with-neurorestore-acd856-with-relevance-to-alzheimers-leading-to-new-patent-application

ACCESSWIRE
13 May 2024

https://www.accesswire.com/849599/alzecure-presents-new-data-regarding-the-trka-nam-pain-project-at-iasp-2024

ACCESSWIRE
03 Apr 2024

https://www.accesswire.com/840248/alzecure-presents-new-preclinical-data-with-neurorestore-acd856-at-leading-alzheimers-conference

ACCESSWIRE
07 Mar 2024

https://www.accesswire.com/839356/alzecure-publishes-clinical-results-supporting-continued-development-of-neurorestore-acd856-against-alzheimers

ACCESSWIRE
05 Mar 2024

https://www.accesswire.com/837726/alzecures-alzheimers-project-neurorestore-acd856-is-granted-an-additional-patent

ACCESSWIRE
29 Feb 2024
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY